Procter and Gamble to distribute OraScan:
This article was originally published in Clinica
Executive Summary
Procter & Gamble is to distribute Zila's (US) oral cancer diagnostic test, OraScan, in the US and 55 other countries, pending regulatory approval (see Clinica No 587, p 20). Block Drug already has the marketing rights for the product in Europe and Australia (see Clinica No 648, p 14). Terms of the agreement have not been disclosed.